These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28652826)

  • 1. Interatrial shunt devices for heart failure with normal ejection fraction: a technology update.
    Cuthbert JJ; Pellicori P; Clark AL
    Med Devices (Auckl); 2017; 10():123-132. PubMed ID: 28652826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.
    Hasenfuß G; Hayward C; Burkhoff D; Silvestry FE; McKenzie S; Gustafsson F; Malek F; Van der Heyden J; Lang I; Petrie MC; Cleland JG; Leon M; Kaye DM;
    Lancet; 2016 Mar; 387(10025):1298-304. PubMed ID: 27025436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Device-based percutaneous treatments to decompress the left atrium in heart failure with preserved ejection fraction.
    Riccardi M; Tomasoni D; Vizzardi E; Metra M; Adamo M
    Heart Fail Rev; 2023 Mar; 28(2):315-330. PubMed ID: 36402928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
    Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
    Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State-of-the-Art Review of Current Therapies for HFpEF: An Overview of Interatrial Septal Device Therapy in Heart Failure.
    Al-Sadawi M; Ortega RR; Ariyaratnam J; Battisha A; Madoukh B; Bukharovich I
    Curr Cardiol Rev; 2021; 17(5):e230421189012. PubMed ID: 33305708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I).
    Feldman T; Komtebedde J; Burkhoff D; Massaro J; Maurer MS; Leon MB; Kaye D; Silvestry FE; Cleland JG; Kitzman D; Kubo SH; Van Veldhuisen DJ; Kleber F; Trochu JN; Auricchio A; Gustafsson F; Hasenfuβ G; Ponikowski P; Filippatos G; Mauri L; Shah SJ
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27330010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double Transseptal Access for Atrial Fibrillation Ablation in the Presence of Investigational Interatrial Shunt Device.
    Guandalini GS; Mazurek JA; Dixit S
    JACC Case Rep; 2021 Jan; 3(1):136-140. PubMed ID: 34317487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interatrial Shunt Device for Heart Failure With Preserved Ejection Fraction.
    Kaye DM; Nanayakkara S
    Front Cardiovasc Med; 2019; 6():143. PubMed ID: 31620452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure.
    Søndergaard L; Reddy V; Kaye D; Malek F; Walton A; Mates M; Franzen O; Neuzil P; Ihlemann N; Gustafsson F
    Eur J Heart Fail; 2014 Jul; 16(7):796-801. PubMed ID: 24961390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.
    Hasenfuss G; Gustafsson F; Kaye D; Shah SJ; Burkhoff D; Reymond MC; Komtebedde J; Hünlich M;
    J Card Fail; 2015 Jul; 21(7):594-600. PubMed ID: 26055211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creation of a restrictive atrial left-to-right shunt: a novel treatment for heart failure.
    De Rosa R; Schranz D
    Heart Fail Rev; 2018 Nov; 23(6):841-847. PubMed ID: 30267205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. InterAtrial Shunt Device (IASD®) implantation - a novel treatment method for heart failure with preserved ejection fraction.
    Kosowski M; Kübler P; Kołodziej A; Krakowiak B; Kustrzycka-Kratochwil D; Sławin J; Sokolski M; Biegus J; Zymliński R; Banasiak W; Ponikowski P; Reczuch K
    Kardiol Pol; 2017; 75(8):736-741. PubMed ID: 28541594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the Efficacy of Interatrial Shunt Devices in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
    Abouzid MR; Ali K
    Cardiol Rev; 2024 Feb; ():. PubMed ID: 38323875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Baseline Hemodynamics on the Effects of a Transcatheter Interatrial Shunt Device in Heart Failure With Preserved Ejection Fraction.
    Wessler J; Kaye D; Gustafsson F; Petrie MC; Hasenfuβ G; Lam CSP; Borlaug BA; Komtebedde J; Feldman T; Shah SJ; Burkhoff D;
    Circ Heart Fail; 2018 Aug; 11(8):e004540. PubMed ID: 30354556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review.
    Burlacu A; Simion P; Nistor I; Covic A; Tinica G
    Heart Fail Rev; 2019 Sep; 24(5):793-803. PubMed ID: 30949860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction.
    Kaye DM; Hasenfuß G; Neuzil P; Post MC; Doughty R; Trochu JN; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Walton A; Muller D; Walters D; Hausleiter J; Raake P; Petrie MC; Bergmann M; Jondeau G; Feldman T; Veldhuisen DJ; Ponikowski P; Silvestry FE; Burkhoff D; Hayward C
    Circ Heart Fail; 2016 Dec; 9(12):e003662. PubMed ID: 27852653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter Implantation of Interatrial Shunt Devices to Lower Left Atrial Pressure in Heart Failure.
    Jørgensen TH; Søndergaard L
    Int J Heart Fail; 2022 Jan; 4(1):12-23. PubMed ID: 36262198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [InterAtrial Shunt Device in diastolic heart failure].
    Hasenfuß G; Jacobshagen C
    Internist (Berl); 2018 Oct; 59(10):1054-1062. PubMed ID: 30194481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure.
    Kaye D; Shah SJ; Borlaug BA; Gustafsson F; Komtebedde J; Kubo S; Magnin C; Maurer MS; Feldman T; Burkhoff D
    J Card Fail; 2014 Mar; 20(3):212-21. PubMed ID: 24487087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on Devices for Diastolic Dysfunction: Options for a No Option Condition?
    Gupta A; Bailey SR
    Curr Cardiol Rep; 2018 Aug; 20(10):85. PubMed ID: 30112586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.